4//SEC Filing
German Christopher Paul 4
Accession 0001104659-25-078814
CIK 0001649904other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 6:47 PM ET
Size
13.0 KB
Accession
0001104659-25-078814
Insider Transaction Report
Form 4
German Christopher Paul
Corporate Controller & CAO
Transactions
- Sale
Common Stock
2025-08-12$95.00/sh−1,500$142,500→ 922 total - Exercise/Conversion
Stock Options (Right to Buy)
2025-08-12−500→ 4,050 totalExercise: $49.23Exp: 2034-02-15→ Common Stock (500 underlying) - Exercise/Conversion
Common Stock
2025-08-12$17.97/sh+1,000$17,970→ 1,922 total - Exercise/Conversion
Stock Options (Right to Buy)
2025-08-12−1,000→ 5,231 totalExercise: $17.97Exp: 2033-04-03→ Common Stock (1,000 underlying) - Exercise/Conversion
Common Stock
2025-08-12$49.23/sh+500$24,615→ 1,422 total
Footnotes (3)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2025.
- [F2]The stock options were granted on April 4, 2023. The options vest and become exercisable as to 25% of the total shares on March 20, 2024 and, thereafter, as to the remaining 75% of the total shares in twelve equal quarterly installments of 6.25% beginning June 20, 2024 and ending March 20, 2027, subject to the Reporting Person's continued service on each such vesting date.
- [F3]The stock options were granted on February 16, 2024. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001260835
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 6:47 PM ET
- Size
- 13.0 KB